REVB

Revelation Biosciences, Inc. REVB

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode REVB SPRC ONCO INDP GTBP SLRX NKGN ATXI PBM AZTR
6M -60.71 % -76.53 % -60.62 % -72.23 % -73.88 % -96.15 % -80.00 % 125.89 % -80.67 % -81.92 %
YTD -97.21 % -82.28 % -97.02 % -91.23 % -72.90 % -97.46 % -92.76 % -65.03 % -93.68 % -89.98 %
1Y -93.94 % -70.14 % -94.44 % -91.57 % -71.65 % -97.18 % -92.22 % -62.51 % -94.48 % -89.41 %
3Y -99.99 % -99.65 % -99.95 % -95.19 % -97.63 % -99.53 % -99.12 % -99.31 % -99.98 % -99.97 %
5Y -100.00 % -99.94 % -100.00 % -99.53 % -99.69 % -99.97 % -99.12 % -99.99 % -99.98 % -99.97 %
10Y -100.00 % -99.94 % -100.00 % -99.98 % -100.00 % -100.00 % -99.12 % -99.99 % -99.98 % -99.97 %
From the beginning -100.00 % -99.94 % -100.00 % -99.98 % -100.00 % -100.00 % -99.12 % -99.99 % -99.98 % -99.97 %

Dividend